Edwards Lifesciences Corporation (EW) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Edwards Lifesciences Corporation, with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | 46.44x | 10.60x | 32.99x | 30.35x | 53.72x | 68.98x |
| P/B Ratio | 4.82x | 4.43x | 6.96x | 7.95x | 13.84x | 12.42x |
| P/S Ratio | 8.22x | 8.13x | 9.23x | 8.58x | 15.43x | 12.95x |
| Profitability | ||||||
| Gross Margin | 78.1% | 79.5% | 79.3% | 78.3% | 76.6% | 74.9% |
| Operating Margin | 27.0% | 25.3% | 28.5% | 31.6% | 30.8% | 29.5% |
| Net Margin | 17.7% | 76.7% | 28.0% | 28.3% | 28.7% | 18.8% |
| EBITDA Margin | 23.6% | 31.7% | 30.6% | 36.4% | 36.1% | 24.5% |
| Liquidity | ||||||
| Current Ratio | 3.72x | 4.18x | 3.38x | 3.03x | 3.08x | 3.46x |
| Quick Ratio | 3.09x | 3.45x | 2.62x | 2.17x | 2.38x | 2.56x |
| Leverage | ||||||
| Debt/Equity | 0.07x | 0.07x | 0.10x | 0.12x | 0.12x | 0.15x |
YoY = year-over-year change. Source: FMP..